Evidence map›Paper›PMID 34198524›Full record

ArticlePlants (Basel, Switzerland)2021

Ingol and Ingenol-Type Diterpenes from

Reham Hammadi, Norbert Kúsz, Csilla Zsuzsanna Dávid, Zoltán Behány, László Papp, Lajos Kemény, Judit Hohmann, Lóránt Lakatos, Andrea Vasas

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Bioactive Compounds fromPharmaceuticals (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Reham HammadiDepartment of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.
Norbert KúszDepartment of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.ORCID 0000-0002-9973-6442
Csilla Zsuzsanna DávidDepartment of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.
Zoltán BehányDepartment of Dermatology and Allergology, University of Szeged, Korányi fasor 6, 6720 Szeged, Hungary.
László PappBotanical Garden, Eötvös Loránd University, Illés u. 25, 1083 Budapest, Hungary.
Lajos KeményDepartment of Dermatology and Allergology, University of Szeged, Korányi fasor 6, 6720 Szeged, Hungary.ORCID 0000-0002-2119-9501
Judit HohmannDepartment of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.
Lóránt LakatosDepartment of Dermatology and Allergology, University of Szeged, Korányi fasor 6, 6720 Szeged, Hungary.
Andrea VasasDepartment of Pharmacognosy, Interdisciplinary Excellence Centre, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.ORCID 0000-0002-1818-7702
University of Szeged · HUEötvös Loránd University · HU

Funding

Economic Development and Innovation Operative Programme GINOP-2.3.2-15-2016-00012, GINOP-2.3.2-15-2016-00015 and GINOP-2.3.2-15-2016-00032New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Funds ÚNKP-20-4
6 · The paper itself

Abstract

Ingenol mebutate, isolated from

Indexed as

actinic keratosiscytotoxicityEuphorbiaceaeEuphorbia trigonaingenol diterpenesingol esterskeratinocyte

Identifiers

PMID34198524
PMCPMC8231945
OpenAlexW3171369196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.